Auspex Pharmaceuticals, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2001-01-01
- Employees
- 35
- Market Cap
- -
- Website
- http://www.auspexpharma.com
Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
- First Posted Date
- 2016-02-04
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Auspex Pharmaceuticals, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT02674321
- Locations
- 🇺🇸
Teva Investigational Site #101, Houston, Texas, United States
Addressing Involuntary Movements in Tardive Dyskinesia
- First Posted Date
- 2014-11-17
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Auspex Pharmaceuticals, Inc.
- Target Recruit Count
- 298
- Registration Number
- NCT02291861
- Locations
- 🇺🇸
Teva Investigational Site 145, Tuscaloosa, Alabama, United States
🇺🇸Teva Investigational Site 107, Anaheim, California, United States
🇺🇸Teva Investigational Site 108, Anaheim, California, United States
Reducing Involuntary Movements in Participants With Tardive Dyskinesia
- First Posted Date
- 2014-07-24
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Auspex Pharmaceuticals, Inc.
- Target Recruit Count
- 343
- Registration Number
- NCT02198794
- Locations
- 🇺🇸
Teva Investigational Site 145, Tuscaloosa, Alabama, United States
🇺🇸Teva Investigational Site 107, Anaheim, California, United States
🇺🇸Teva Investigational Site 108, Anaheim, California, United States
Aim to Reduce Movements in Tardive Dyskinesia
- First Posted Date
- 2014-07-21
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Auspex Pharmaceuticals, Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT02195700
Alternatives for Reducing Chorea in Huntington Disease
- First Posted Date
- 2013-07-12
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Auspex Pharmaceuticals, Inc.
- Target Recruit Count
- 119
- Registration Number
- NCT01897896
- Locations
- 🇺🇸
Teva Investigational Site 057, Birmingham, Alabama, United States
🇺🇸Teva Investigational Site 038, Phoenix, Arizona, United States
🇺🇸Teva Investigational Site 298, Fayetteville, Arkansas, United States